Olympus Corp (STU:OLY1)
€ 14.77 -0.035 (-0.24%) Market Cap: 16.80 Bil Enterprise Value: 16.61 Bil PE Ratio: 37.94 PB Ratio: 4.10 GF Score: 89/100

Olympus Corp at JPMorgan Healthcare Conference Transcript

Jan 15, 2020 / 04:00PM GMT
Release Date Price: €14.4 (+2.86%)
Naomi Kumagai
JP Morgan Chase & Co, Research Division - Senior Analyst

Good morning, everyone. Welcome to the conference. My name is Naomi Kumagai, Japan pharma and med tech analyst at JPMorgan. It's my great pleasure to introduce Mr. Takeuchi, President and CEO of Olympus. Breakout will be in Georgian room. And with that, I'll turn it over to Mr. Takeuchi.

Yasuo Takeuchi
Olympus Corporation - President, CEO, Representative Executive Officer & Director

Thank you, Kumagai-san, for your kind introduction.

Today, I am privileged to be here for the first time as Olympus. Good morning, everyone. I am Yasuo Takeuchi, CEO and President of Olympus. Before jumping into main topic, I want to share a little bit of who I am. I am a pure breed of Olympus. This year marks my 40th anniversary working here, and took office last April. But half of my career was built outside of Japan, that gave me opportunities to look at my own company performance with eyes of outsider, and I have come to believe that Olympus has a potential for much stronger growth if we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot